Prezcobix and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prezcobix (cobicistat; darunavir ethanolate) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include fatigue among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Prezcobix and Dilaudid. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Prezcobix?

Prezcobix has active ingredients of cobicistat; darunavir ethanolate. eHealthMe is studying from 2,113 Prezcobix users. Check the latest studies of Prezcobix.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.



On Jul, 19, 2026

16 people who take Prezcobix and Dilaudid together, and have interactions are studied.

Prezcobix and Dilaudid drug interactions.

What are the common drug interactions of Prezcobix and Dilaudid, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Cellulitis (infection under the skin)
  5. Dizziness
  6. Drug ineffective
  7. Emotional distress
  8. Euphoric mood (excessively happy but may become angry or irritable)
  9. Faeces discoloured
  10. Headache (pain in head)

male:

  1. Renal failure (kidney dysfunction)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Impaired work ability
  7. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  8. Nephrolithiasis (calculi in the kidneys)
  9. Renal transplant
  10. Tooth loss

What are the common drug interactions of Prezcobix and Dilaudid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hand fracture
  2. Rib fracture
  3. Renal failure (kidney dysfunction)
  4. Bone density decreased
  5. Foot fracture
  6. Multiple fractures
  7. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Renal impairment (severely reduced kidney function)
  10. Gait disturbance

40-49:

  1. Anxiety
  2. Emotional distress
  3. Azotaemia (excess of urea or other nitrogenous compounds in the blood)
  4. Decreased activity
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Impaired work ability
  9. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  10. Nephrolithiasis (calculi in the kidneys)

50-59:

  1. Cellulitis (infection under the skin)
  2. Dizziness
  3. Faeces discoloured
  4. Fatigue (feeling of tiredness)
  5. Localised infection (infection at the single location)
  6. Ocular icterus (presence of jaundice seen in the sclera of the eye)
  7. Poor quality sleep
  8. Yellow skin

60+:

n/a

What are the existing conditions these people have? *

  1. Hiv Infection: 14 people, 87.50%
  2. Procedural Pain: 4 people, 25.00%
  3. Infection: 4 people, 25.00%
  4. High Blood Pressure: 4 people, 25.00%
  5. High Blood Cholesterol: 4 people, 25.00%
  6. Diabetes: 4 people, 25.00%
  7. Hepatitis B: 3 people, 18.75%
  8. Peripheral Swelling: 2 people, 12.50%
  9. Hepatitis C: 2 people, 12.50%
  10. Sinusitis (inflammation of sinus): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Prezcobix and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prezcobix and Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prezcobix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prezcobix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cobicistat; darunavir ethanolate and hydromorphone hydrochloride (the active ingredients of Prezcobix and Dilaudid, respectively), and Prezcobix and Dilaudid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: